Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 5
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

349.0000 -1.80 (-0.51%)

NSE Apr 30, 2025 15:31 PM

45.04% Fall from 52W High

Volume: 244.4K

Aarti Drugs Ltd.

30 Oct 2022, 12:00AM

349.00

-0.51%

Result Update:Aarti Drugs

Buy: Aarti Drugs Ltd.

Recommendation Target

Axis Direct

Aarti Drugs could be benefitted in upcoming quarters, we upgrade to BUY on Aarti Drugs with Target Price of Rs 545

Aarti Drugs Ltd. has lost -27.90% in the last 6 Months